Skip to content

Dexmedetomidine versus epidural analgesia to reduce surgical stress in adults

Intravenous dexmedetomidine versus epidural analgesia for suppression of neuroendocrine and metabolic stress response in patients undergoing abdominal surgeries general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016289
Enrollment
50
Registered
2018-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N859- Noninflammatory disorder of uterus, unspecified Health Condition 2: K638- Other specified diseases of intestine Health Condition 3: R103- Pain localized to other parts of lower abdomen

Interventions

Intervention1: Dexmedetomidine infusion: Intravenous dexmedetomidine infusion in loading dose of 0.6μg/kg over 10 min before induction Maintenance infusion 0.4 μg/kg/hr throughout the surgery till

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II patients scheduled for elective abdominal surgery under general anaesthesia requiring endotracheal intubation and epidural catheter insertion will be included

Exclusion criteria

Exclusion criteria: Laparoscopic abdominal surgery Contraindications to epidural administration like bleeding disorders, deranged coagulation profile, local site infection, neurological or spinal disease etc. History of psychiatric disorders. Obesity (BMI > 30 kg/m2) Patients on beta blockers or those who have been on continuous steroid therapy for > 5 days in the last one year. History of allergy to any of the drugs being used in the study. Known case of endocrine abnormalities, pheochromocytoma, carcinoid tumor etc. H/o present or past malignancy.

Design outcomes

Primary

MeasureTime frame
Serum cortisolTimepoint: Before induction, 30 min after surgical incision, at the time of extubation, 2 hr post-extubation, 24 hr after surgery

Secondary

MeasureTime frame
Blood GlucoseTimepoint: Before induction, 30 min after surgical incision, at the time of extubation, 2 hr post-extubation, 24 hr after surgery;Blood UreaTimepoint: Before induction, 24 hr after surgery;Emergence characteristicsTimepoint: 2 min after extubation;Heart Rate, mean arterial pressureTimepoint: Baseline, after loading drug, just before and immediately after tracheal intubation, at the time of surgical incision, every 10 min for the first 30 min and then every 30 min till completion of surgery, after skin wound closure, at the time of extubation and every 30 min post-operatively till 120 min.

Countries

India

Contacts

Public ContactDr Vishal Kamal

University College of Medical Sciences and GTB Hospital, Delhi

rashmichabra@yahoo.com9911317334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026